189 related articles for article (PubMed ID: 37710072)
1. RHAMM/hyaluronan inhibit β-catenin degradation, enhance downstream signaling, and facilitate fibrosarcoma cell growth.
Berdiaki A; Thrapsanioti LN; Giatagana EM; K Karamanos N; C Savani R; N Tzanakakis G; Nikitovic D
Mol Biol Rep; 2023 Nov; 50(11):8937-8947. PubMed ID: 37710072
[TBL] [Abstract][Full Text] [Related]
2. Receptor for hyaluronic acid- mediated motility (RHAMM) regulates HT1080 fibrosarcoma cell proliferation via a β-catenin/c-myc signaling axis.
Kouvidi K; Berdiaki A; Tzardi M; Karousou E; Passi A; Nikitovic D; Tzanakakis GN
Biochim Biophys Acta; 2016 Apr; 1860(4):814-24. PubMed ID: 26825774
[TBL] [Abstract][Full Text] [Related]
3. Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion.
Kouvidi K; Berdiaki A; Nikitovic D; Katonis P; Afratis N; Hascall VC; Karamanos NK; Tzanakakis GN
J Biol Chem; 2011 Nov; 286(44):38509-38520. PubMed ID: 21914806
[TBL] [Abstract][Full Text] [Related]
4. The roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression.
Nikitovic D; Kouvidi K; Karamanos NK; Tzanakakis GN
Biomed Res Int; 2013; 2013():929531. PubMed ID: 24083250
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan.
Samuel SK; Hurta RA; Spearman MA; Wright JA; Turley EA; Greenberg AH
J Cell Biol; 1993 Nov; 123(3):749-58. PubMed ID: 7693717
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFβ receptor interaction via CD44-PKCδ.
Park D; Kim Y; Kim H; Kim K; Lee YS; Choe J; Hahn JH; Lee H; Jeon J; Choi C; Kim YM; Jeoung D
Mol Cells; 2012 Jun; 33(6):563-74. PubMed ID: 22610405
[TBL] [Abstract][Full Text] [Related]
7. bFGF induces changes in hyaluronan synthase and hyaluronidase isoform expression and modulates the migration capacity of fibrosarcoma cells.
Berdiaki A; Nikitovic D; Tsatsakis A; Katonis P; Karamanos NK; Tzanakakis GN
Biochim Biophys Acta; 2009 Oct; 1790(10):1258-65. PubMed ID: 19577615
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid, CD44 and RHAMM regulate myoblast behavior during embryogenesis.
Leng Y; Abdullah A; Wendt MK; Calve S
Matrix Biol; 2019 May; 78-79():236-254. PubMed ID: 30130585
[TBL] [Abstract][Full Text] [Related]
9. TGFβ and Hippo Pathways Cooperate to Enhance Sarcomagenesis and Metastasis through the Hyaluronan-Mediated Motility Receptor (HMMR).
Ye S; Liu Y; Fuller AM; Katti R; Ciotti GE; Chor S; Alam MZ; Devalaraja S; Lorent K; Weber K; Haldar M; Pack MA; Eisinger-Mathason TSK
Mol Cancer Res; 2020 Apr; 18(4):560-573. PubMed ID: 31988250
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells.
Song JM; Im J; Nho RS; Han YH; Upadhyaya P; Kassie F
Mol Carcinog; 2019 Mar; 58(3):321-333. PubMed ID: 30365189
[TBL] [Abstract][Full Text] [Related]
11. Developmental regulation of hyaluronan-binding protein (RHAMM/IHABP) expression in early bovine embryos.
Stojkovic M; Krebs O; Kölle S; Prelle K; Assmann V; Zakhartchenko V; Sinowatz F; Wolf E
Biol Reprod; 2003 Jan; 68(1):60-6. PubMed ID: 12493696
[TBL] [Abstract][Full Text] [Related]
12. Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression.
Mohapatra S; Yang X; Wright JA; Turley EA; Greenberg AH
J Exp Med; 1996 Apr; 183(4):1663-8. PubMed ID: 8666924
[TBL] [Abstract][Full Text] [Related]
13. Loss of the hyaluronan receptor RHAMM prevents constrictive artery wall remodeling.
Ma X; Pearce JD; Wilson DB; English WP; Edwards MS; Geary RL
J Vasc Surg; 2014 Mar; 59(3):804-13. PubMed ID: 23768790
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 2 (TLR2), transforming growth factor-β, hyaluronan (HA), and receptor for HA-mediated motility (RHAMM) are required for surfactant protein A-stimulated macrophage chemotaxis.
Foley JP; Lam D; Jiang H; Liao J; Cheong N; McDevitt TM; Zaman A; Wright JR; Savani RC
J Biol Chem; 2012 Oct; 287(44):37406-19. PubMed ID: 22948158
[TBL] [Abstract][Full Text] [Related]
15. Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin.
Matou-Nasri S; Gaffney J; Kumar S; Slevin M
Int J Oncol; 2009 Oct; 35(4):761-73. PubMed ID: 19724912
[TBL] [Abstract][Full Text] [Related]
16. The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
Niedworok C; Kretschmer I; Röck K; Vom Dorp F; Szarvas T; Heß J; Freudenberger T; Melchior-Becker A; Rübben H; Fischer JW
PLoS One; 2013; 8(9):e75681. PubMed ID: 24069434
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activation.
Gouëffic Y; Guilluy C; Guérin P; Patra P; Pacaud P; Loirand G
Cardiovasc Res; 2006 Nov; 72(2):339-48. PubMed ID: 16934786
[TBL] [Abstract][Full Text] [Related]
18. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight hyaluronan induces migration of human choriocarcinoma JEG-3 cells mediated by RHAMM as well as by PI3K and MAPK pathways.
Mascaró M; Pibuel MA; Lompardía SL; Díaz M; Zotta E; Bianconi MI; Lago N; Otero S; Jankilevich G; Alvarez E; Hajos SE
Histochem Cell Biol; 2017 Aug; 148(2):173-187. PubMed ID: 28365860
[TBL] [Abstract][Full Text] [Related]
20. RHAMM expression tunes the response of breast cancer cell lines to hyaluronan.
Carvalho AM; Soares da Costa D; Reis RL; Pashkuleva I
Acta Biomater; 2022 Jul; 146():187-196. PubMed ID: 35577044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
